1. Abstract 77: A Phase I Open-Label Study Evaluating the Safety of Acellular Adipose Tissue (AAT), a Novel Soft Tissue Reconstruction Solution, in Healthy Volunteers. Issue 4 (April 2017) Authors: Payne, Rachael M.; Anderson, Amy; Parrillo, Alexis; Sadtler, Kaitlyn; Wu, Iwen; Aston, Jeffrey; Steiner, Allison; Cooney, Carisa M.; Cooney, Damon S.; Byrne, Patrick; Pardoll, Drew; Elisseeff, Jennifer Journal: Plastic and reconstructive surgery Issue: Volume 5:Issue 4s(2017.)supplement 4s Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Real-world 12-month outcomes of patients with type 2 diabetes mellitus (T2DM) treated with canagliflozin in a US managed care setting. (October 2016) Authors: Chow, Wing; Buysman, Erin; Rupnow, Marcia; Anderson, Amy; Henk, Henry; Fegade, Mayuresh Journal: Diabetes research and clinical practice Issue: Volume 120(2016)Supplement 1 Page Start: S118 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 338 Emerging insights on the association of tumor molecular phenotype with clinical benefit in metastatic colorectal cancer (mCRC) subjects treated with AB928 + modified FOLFOX-6 (mFOLFOX-6). (10th December 2020) Authors: Udyavar, Akshata; Cecchini, Michael; DiRenzo, Daniel; Cho, Sean; Seitz, Lisa; Zhang, Kristen; Young, Stephen; Anderson, Amy; Gerrick, Kimberline; Walters, Matthew; Gilbert, Houston; Gardner, Olivia; Quah, Cheng; Jaen, Juan; Grossman, William Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A206 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 338 Emerging insights on the association of tumor molecular phenotype with clinical benefit in metastatic colorectal cancer (mCRC) subjects treated with AB928 + modified FOLFOX-6 (mFOLFOX-6). (9th November 2020) Authors: Udyavar, Akshata; Cecchini, Michael; DiRenzo, Daniel; Cho, Sean; Seitz, Lisa; Zhang, Kristen; Young, Stephen; Anderson, Amy; Gerrick, Kimberline; Walters, Matthew; Gilbert, Houston; Gardner, Olivia; Quah, Cheng; Jaen, Juan; Grossman, William Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A363 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. SAT0003 PIM1 REGULATES CD4+ T CELL EFFECTOR FUNCTION IN EARLY RHEUMATOID ARTHRITIS AND HAS POTENTIAL FOR USE AS A NOVEL, MEASURABLE THERAPEUTIC TARGET. (June 2019) Authors: Maney, Nicola J.; Anderson, Amy; Isaacs, John; Pratt, Arthur Journal: Annals of the rheumatic diseases Issue: Volume 78(2019)Supplement 2 Page Start: 1066 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. AB0024 WHOLE BLOOD ENDOGENOUS RETROELEMENT ACTIVITY ASSOCIATES WITH ANTI-CCP TITRES IN EARLY DRUG NAïVE RA AND IS PREFERENTIALLY INCREASED IN CD5+ AND NAïVE B CELLS. (June 2019) Authors: Cooles, Faye; Pedrola, Gemma Vidal; Anderson, Amy; Naamane, Najib; Skelton, Andrew; Pratt, Arthur; Hilkens, Catharien; Shukla, Ruchi; Isaacs, John Journal: Annals of the rheumatic diseases Issue: Volume 78(2019)Supplement 2 Page Start: 1478 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. FRI0009 MOLECULAR PROFILING OF CIRCULATING B-LYMPHOCYTES REVEALS THE SUPERIOR PERFORMANCE OF METHYLOME OVER TRANSCRIPTOME DATA FOR DISCRIMINATING RHEUMATOID ARTHRITIS PATIENTS IN AN EARLY ARTHRITIS CLINIC: IMPLICATIONS FOR TRANSLATING "BIG DATA" INTO CLINICALLY USEFUL TOOLS. (June 2019) Authors: Naamane, Najib; Thalayasingam, Nishanthi; Nair, Nisha; Clar, Alexander; Anderson, Amy; Lendrem, Dennis; Reynard, Louise; Eyre, Stephen; Barton, Anne; Isaacs, John; Pratt, Arthur Journal: Annals of the rheumatic diseases Issue: Volume 78(2019)Supplement 2 Page Start: 665 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Cost of Disease Progression in Patients with Metastatic Breast, Lung, and Colorectal Cancer. (22nd February 2019) Authors: Reyes, Carolina; Engel‐Nitz, Nicole M.; DaCosta Byfield, Stacey; Ravelo, Arliene; Ogale, Sarika; Bancroft, Tim; Anderson, Amy; Chen, May; Matasar, Matthew Journal: Oncologist Issue: Volume 24:Number 9(2019) Page Start: 1209 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Cost of Disease Progression in Patients with Chronic Lymphocytic Leukemia, Acute Myeloid Leukemia, and Non‐Hodgkin's Lymphoma. (26th February 2019) Authors: Reyes, Carolina; Engel‐Nitz, Nicole M.; DaCosta Byfield, Stacey; Ravelo, Arliene; Ogale, Sarika; Bancroft, Tim; Anderson, Amy; Chen, May; Matasar, Matthew Journal: Oncologist Issue: Volume 24:Number 9(2019) Page Start: 1219 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Treatment patterns and burden of complications associated with sickle cell disease: A US retrospective claims analysis. Issue 4 (6th October 2022) Authors: Manwani, Deepa; Burnett, Arthur L.; Paulose, Jincy; Yen, Glorian P.; Burton, Tanya; Anderson, Amy; Wang, Sara; Lee, Soyon; Saraf, Santosh L. Journal: EJHaem Issue: Volume 3:Issue 4(2022) Page Start: 1135 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗